A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC.

NCT01732640 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Slow accrual and high levels of toxicity lead to early termination.

Conditions

Squamous Cell Carcinoma of the Head and Neck

Interventions

DRUG: Afatinib
DRUG: Paclitaxel
DRUG: Carboplatin
DRUG: Cisplatin
RADIATION: Intensity Modulated Radiation Therapy

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]
[object Object]